Medicinal Research Reviews

Medicinal Research Reviews is a review-only journal on medicinal research published by John Wiley and Sons. Founded in 1981 and appearing bimonthly, it carries print ISSN 0198-6325 and electronic ISSN 1098-1128, and reports a 2025 impact factor of 13.6.Medicinal Research Reviews 是约翰·威利父子出版公司出版的药物研究综述期刊，1981 年创刊，双月刊，印刷版编号 0198-6325、电子版编号 1098-1128，2025 年影响因子为 13.6，为只发表综述的刊物。^[1]

Scope

• Scope: the journal publishes timely, critical reviews and opinion-based articles on topics related to medicinal research, broadly defined, to which the authors have made significant contributions.学科定位： 发表药物研究广义领域及时、批判性的综述与观点性文章，要求作者本人对所评主题有实质性贡献。^[2]
• Topics: pathophysiology of important diseases and disease vectors, approaches to disease treatment, molecular characterisation of therapeutic targets, new methodologies for finding therapies, genomics and proteomics, structure-activity relationships of compound series, new imaging and diagnostic tools, drug metabolism and delivery, and the chemical, pharmacological, pharmacokinetic, pharmacodynamic and clinical properties of important drugs.收录主题： 重要疾病与疾病载体的病理生理，疾病治疗方法，治疗靶点的分子特性，寻找疗法的新方法学，基因组学与蛋白质组学，药物系列构效关系，新成像与诊断工具，药物代谢与药物递送，重要药物的化学、药理、药代、药效与临床特性。
• Article types: the journal carries reviews only, in three formats, namely short insight pieces, narrowly scoped mini reviews and long review articles, with systematic reviews and meta-analyses explicitly out of scope and original research not accepted.文章体裁： 只发表综述类文章，分三种：观点性短文、窄口径综述与长篇综述，系统综述与荟萃分析明确不在收稿范围，不收原创研究。
• Publishing model: a subscription journal that offers an open access option, with Creative Commons licences available to authors choosing that route.出版模式： 订阅刊并提供开放获取选项，作者可选知识共享许可发表。
• Indexing and metrics: a 2025 impact factor of 13.6 and a CiteScore of 29.1, with the official page reporting an acceptance rate of 8%.收录与指标： 2025 年影响因子 13.6、CiteScore 29.1，官方页面显示录用率 8%。

History

• Founded: the journal was founded in 1981 with volumes numbered consecutively by year, reaching volume 46 by 2026, and the official editorial board page names George de Stevens as founding editor.创刊： 1981 年创刊，卷号按年连续编号，2026 年为第 46 卷；官网编委页列 George de Stevens 为创刊编辑。^[3]
• Title history: no renaming on record, the title Medicinal Research Reviews has been in use since 1981.更名史： 无更名记录，创刊至今沿用 Medicinal Research Reviews 刊名。
• Editorial transitions: after founding editor George de Stevens, the editorship passed through Binghe Wang and Amanda E. Hargrove before Laura Mercolini took over in February 2026.主编更替： 创刊编辑 George de Stevens 之后，由 Binghe Wang 与 Amanda E. Hargrove 先后主政，2026 年 2 月起由 Laura Mercolini 接任。^[4]

Editors

• Editor-in-chief: Laura Mercolini, professor of pharmaceutical analysis and medicinal chemistry at the University of Bologna in Italy, where she leads a pharmaceutical analysis laboratory, and editor-in-chief since 1 February 2026.现任主编： Laura Mercolini，意大利博洛尼亚大学药物分析与药物化学教授，领导药物分析实验室，2026 年 2 月 1 日起接任主编。^[4]
• Former editors-in-chief: Amanda E. Hargrove, professor in the Department of Chemistry at Duke University in the United States, working on small-molecule probes of RNA, and before her Binghe Wang of Georgia State University in the United States.前任主编： Amanda E. Hargrove，美国杜克大学化学系教授，研究方向为 RNA 的小分子探针；更早任主编的 Binghe Wang 任职于美国佐治亚州立大学。
• Editorial team: deputy editor Sandip B. Bharate of the CSIR-Indian Institute of Chemical Technology in Hyderabad, India, alongside associate editors José Luis Capelo of NOVA University Lisbon in Portugal, Allan B. Gamble of the University of Otago in New Zealand, Jun Wang of the University of Arizona, Shuai Wang of Fudan University and Weiping Wang of the University of Hong Kong.编辑团队： 副编辑 Sandip B. Bharate，任职于印度海得拉巴 CSIR 印度化学技术研究所；副编辑另包括葡萄牙新里斯本大学的 José Luis Capelo、新西兰奥塔哥大学的 Allan B. Gamble、美国亚利桑那大学的 Jun Wang、复旦大学的 Shuai Wang 与香港大学的 Weiping Wang。
• Editorial board: some 30 editorial board members, internationally drawn from the United States, Portugal, Australia, China, Belgium, Italy, the United Kingdom and Spain, among others.编委构成： 编辑委员会约 30 名成员，国际化，覆盖美国、葡萄牙、澳大利亚、中国、比利时、意大利、英国与西班牙等。
• Submission and review: submissions go through ScholarOne under single anonymized peer review, and since November 2021 the former pre-submission proposal step has been replaced by a review summary sheet submitted with the full manuscript.投稿与评审： 经 ScholarOne 系统投稿，实行单盲评审；2021 年 11 月起取消投稿前提纲预审，改为随全文提交综述概要表。